Resumen de acción 3692
Hansoh Pharmaceutical Group Company Limited, un holding de inversiones, se dedica a la investigación, desarrollo, fabricación y venta de productos farmacéuticos en la República Popular China. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 5/6 |
| Salud financiera | 5/6 |
| Dividendos | 2/6 |
Recompensas
Análisis de riesgos
Competidores de Hansoh Pharmaceutical Group Company Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | HK$18.52 |
| Máximo en las últimas 52 semanas | HK$22.80 |
| Mínimo de 52 semanas | HK$11.18 |
| Beta | 0.65 |
| 1Cambio en 1 mes | -8.32% |
| Variación en 3 meses | 7.42% |
| Cambio de 1 año | 25.30% |
| 3Variación en 3 años | 9.33% |
| Variación en 5 años | -19.83% |
| Variación desde la OPV | -5.03% |
Noticias y actualizaciones recientes
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly
Nov 21
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Recent updates
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly
Nov 21Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Rentabilidad de los accionistas
| 3692 | HK Pharmaceuticals | Mercado HK | |
|---|---|---|---|
| 7D | 8.4% | 0.07% | -0.6% |
| 1Y | 25.3% | -10.2% | 9.6% |
Rentabilidad vs. Industria: 3692 superó a la industria Hong Kong Pharmaceuticals, que obtuvo un rendimiento del -10.2% el año pasado.
Rentabilidad vs. Mercado: 3692 superó al mercado Hong Kong, que obtuvo un rendimiento del 9.6% el año pasado.
Volatilidad de los precios
| 3692 volatility | |
|---|---|
| 3692 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 6.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Precio estable de las acciones: 3692 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 3692 (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1995 | 9,099 | Huijuan Zhong | www.hspharm.com |
Hansoh Pharmaceutical Group Company Limited, un holding de inversiones, se dedica a la investigación, el desarrollo, la fabricación y la venta de productos farmacéuticos en la República Popular China. La empresa suministra productos para áreas terapéuticas como antitumorales, antiinfecciosas, enfermedades del sistema nervioso central, oncología, enfermedades metabólicas y autoinmunes, etc. Sus principales productos son Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Hengmu, Mailingda, Hengsen, XINYUE, Saint Luolai, Fulaimei, Pulaitan, Tanneng, Ameining, Oulanning, Ruibote, Fulaidi, Fulairui y comprimidos Puruian. La empresa atiende a distribuidores de productos farmacéuticos.
Resumen de fundamentos de Hansoh Pharmaceutical Group Company Limited
| Estadísticas fundamentales de 3692 | |
|---|---|
| Capitalización bursátil | HK$109.90b |
| Beneficios(TTM) | HK$5.06b |
| Ingresos (TTM) | HK$13.00b |
21.7x
Ratio precio-beneficio (PE)8.5x
Ratio precio-ventas (PS)¿Está 3692 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 3692 | |
|---|---|
| Ingresos | CN¥12.10b |
| Coste de los ingresos | CN¥1.09b |
| Beneficio bruto | CN¥11.01b |
| Otros gastos | CN¥6.30b |
| Beneficios | CN¥4.71b |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.79 |
| Margen bruto | 91.01% |
| Margen de beneficio neto | 38.97% |
| Ratio deuda/patrimonio | 0.1% |
¿Cómo se ha desempeñado 3692 a largo plazo?
Ver rendimiento histórico y comparativa